Monographie - Durvalumab

Son güncelleme :
19/11/2024

Durvalumab

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Imfinzi

Almanya, Amerika Birleşik Devletleri, Büyük Britanya, Fransa, İsviçre, Kanada

Kaynaklar : Durvalumab

	tip	yayın
4608	Laboratuar	Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021) Astra Zeneca 2021
4767	Dergi	Almasi K, Thiesen J, Krämer I. Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1
4772	Dergi	Porlier A, Gagnon P-Y, Chénard V, Michael N-J, Simard C, Drolet B. Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage? J Pharm Sci 2023 ; 112, 9: 2412-2418.

Mentions Légales